3M Co. is one I might add to your list as well. Cuno Division is one reason.
3M’s strong healthcare business is underappreciated by investors, IMO. However, it comprises only 15-20% of 3M’s overall sales, so even I would not characterize 3M as a biotech company :- )
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”